Mihika Shah et al. 2020. Risk of Arterial and Venous Thromboembolic Events with Bevacizumab, an Antibody against Vascular Endothelial Growth Factor A (VEGF-A): A Systematic Review and Meta-Analysis. Global Journal of Medical Research. 20, B1 (Jan. 2020), 71–85.